Potential sources of heterogeneity, including cancer type, geographic area, SIRT1 expression level, primary antibody used for the immunohistochemical evaluation of SIRT1 expression, method of data extraction, confounding adjustment, and quality score, were assessed with meta-regression analysis. This evidence concerns the gene SIRT1 and cancer.